Page 6171
Sep 21, 2021
New Artificial Intelligence Tool Accelerates Discovery of Truly New Materials
Posted by Genevieve Klien in categories: robotics/AI, sustainability, transportation
The new artificial intelligence tool has already led to the discovery of four new materials.
Researchers at the University of Liverpool have created a collaborative artificial intelligence tool that reduces the time and effort required to discover truly new materials.
Reported in the journal Nature Communications, the new tool has already led to the discovery of four new materials including a new family of solid state materials that conduct lithium. Such solid electrolytes will be key to the development of solid state batteries offering longer range and increased safety for electric vehicles. Further promising materials are in development.
Sep 21, 2021
COLLIDE! Why particle physics at Oxford matters… | Facebook
Posted by Alan Jurisson in categories: cosmology, particle physics
Thu, Sep 23 at 8 AM PDT.
Join us on-line from 4pm to 7pm on Thursday 23 September for a livestream event to learn about particle physics research at Oxford. Hear from researchers studying High Energy collisions, and phenomena like dark matter, antimatter, and neutrinos; follow a guided tour of our Minecraft model of the CERN laboratory; and watch exciting demonstrations from the Accelerate! show. Oxford particle physicists will be available through the evening to answer your questions.
Live, via the Oxford Physics YouTube channel. Everyone is welcome, regardless their knowledge of physics.
Continue reading “COLLIDE! Why particle physics at Oxford matters… | Facebook” »
Sep 21, 2021
Musk Says You Need To Be A Good Driver To Become FSD Beta Tester
Posted by Kelvin Dafiaghor in categories: Elon Musk, sustainability, transportation
How true Eric Klien?
Elon Musk has announced that Tesla owners who want to be FSD Beta testers will have to accept being monitored and then drive safely for seven days.
Sep 21, 2021
Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
Posted by Omuterema Akhahenda in category: biotech/medical
Merck, known as MSD outside the US and Canada, and Ridgeback Biotherapeutics have announced that its MOV-e-AHEAD study has started to enrol its first participants to test antiviral molnupiravir in post-exposure prophylaxis of COVID-19 infection.
The global study will include approximately 1,332 participants who are 18 years or over and reside in the same household as someone with laboratory-confirmed SARS-CoV-2 infection, has at least one sign or symptom of COVID-19 and has not had those signs and symptoms for more than five days.
Participants will be randomised onto molnupiravir, an investigational oral antiviral therapeutic, or placebo every 12 hours for 5 days. The trial will not look at vaccinated people, those who have had COVID-19 before or anyone showing signs or symptoms of infection.
Continue reading “Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention” »
This video explains periodic table and trends of periodic table.
Thank You For Watching.
Sep 21, 2021
Sex robots to become ‘super intelligent’ by 2050 and see owners as ‘slaves’
Posted by TJ Wass in categories: robotics/AI, sex
EXCLUSIVE Pricier sex robots have already been equipped with a range of artificial intelligence features, with customers shelling out thousands on groundbreaking synthetic companions dailystar.
Sep 21, 2021
Novel assay finds new mechanism underlying red blood cell aging
Posted by Kevin Huang in categories: biotech/medical, chemistry, life extension
Red blood cells are the most abundant cell type in blood, carrying oxygen throughout the human body. In blood circulation, they repetitively encounter various levels of oxygen tension. Hypoxia, a low oxygen tension condition, is a very common micro-environmental factor in physiological processes of blood circulation and various pathological processes such as cancer, chronic inflammation, heart attacks and stroke. In addition, an interplay between poor cellular deformability and impaired oxygen delivery is found in various pathological processes such as sickle cell disease. Sickle red blood cells simultaneously undergo drastic mechanical deformation during the sickling and unsickling process.
The interactions between hypoxia and cell biomechanics and the underlying biochemical mechanisms of the accelerated damage in diseased red blood cells are well understood, however, the exact biomechanical consequences of hypoxia contributing to red blood cell degradation (aging) remains elusive.
Researchers from Florida Atlantic University’s College of Engineering and Computer Science, in collaboration with the Massachusetts Institute of Technology (MIT), sought to identify the role of hypoxia on red blood cell aging via the biomechanical pathways. In particular, they examined hypoxia-induced impairment of red blood cell deformability at the single cell level, compared the differences between non-cyclic hypoxia and cyclic hypoxia, and documented any cumulative effect vs. hypoxia cycles, such as aspects that have not been studied quantitatively. Red blood cell deformability is an important biomarker of its functionality.
Sep 21, 2021
How firefly flashes illuminate the physics of complex systems
Posted by Jose Ruben Rodriguez Fuentes in category: physics
Solving the mystery of how and why fireflies flash in time can illuminate the physics of complex systems by Orit Peleg + BIO.
Sep 21, 2021
Elon Musk said SpaceX’s first-ever civilian crew had ‘challenges’ with the toilet and promised an upgrade for the next flight
Posted by Kelvin Dafiaghor in categories: Elon Musk, space travel
SpaceX CEO Musk did not elaborate on what toilet “challenges” the crew of the Inspiration4 mission faced or how exactly the toilet would be upgraded.